Stem Cell-Like Cancer Cells Resistant To Standard Therapy, Responsive To Targeted Therapy
Science Daily Tue, 29 Apr 2008 3:23 PM PDT
A comparison of breast cancer biopsies before and after treatment show that a subset of cells, which have stem cell-like properties, are resistant to standard chemotherapy. Tumors treated with lapatinib, which inhibits a pathway important for self-renewal, retained a smaller fraction of these tumorigenic cells after therapy. |
UW stem cell scientist gets prestigious honor
The Capital Times Tue, 29 Apr 2008 12:48 PM PDT
UW-Madison stem cell scientist James Thomson has been elected to the National Academy of Sciences. The announcement of Thomson's election was made Tuesday by the university. Thomson is among 72 new fellows going into the 145-year-old academy this year, considered one of the most prestigious honors in American science. In 1998, Thomson was the first scientist to isolate and culture human ... |
Bra Wonder Without Silicon - Thanks to Stem Cell Concentrated Own-Fat
PR Newswire via Yahoo! Finance Tue, 29 Apr 2008 0:00 AM PDT
It is still widely believed that the use of silicon is state-of-the-art in breast enlargement. That is not so. Thanks to recent research on stem cells, women today need not rely on plastic pads if they opt for larger breasts. |
The hard sell for stem-cell potions
The Morning Call Tue, 29 Apr 2008 6:16 AM PDT
Anti-aging creams' newest gimmick sounds scientific but may do little ''Restore and renew.'' ''Significantly reduces the loss of cells in the epidermis.'' ''Regenerate cells and repair tissue.'' |
Pair honoured for breast cancer research
AAP via Yahoo!7 News Tue, 29 Apr 2008 6:15 PM PDT
A husband-and-wife team who grew a breast from a single mouse stem cell have been honoured for their contribution to breast cancer research. |
Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
PR Newswire via Yahoo! Finance Tue, 29 Apr 2008 2:00 AM PDT
Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that Matthew Schissler, CEO, in an Internet interview with Francis Gaskins, said 2007 acquisitions resulted in an 820 percent increase in assets and a 600 percent increase in gross profits. |
| |
|
